VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ESMO Breast 2022 | Immunotherapy insights from ESMO Breast 2022

Céline Blaye • 4 May 2022
ESMO Breast 2022
Breast Cancer
Immuno-Oncology

Céline Blaye, MD, University of Bordeaux, Bordeaux, France, on what she enjoyed most at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 meeting. This interview took place at the European Society for Medical Oncology (ESMO) Breast Cancer 2022 congress in Berlin, Germany.

More from Céline Blaye

1:30
The role of myeloid-derived suppressor cells in breast cancer
Céline Blaye • 4 May 2022
1:23
Exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
Céline Blaye • 4 May 2022
1:22
Immunological signatures to predict outcomes in patients with TNBC
Céline Blaye • 4 May 2022

Related Videos

2:52
IMpassion130 study: improvement in OS and PFS for IIT and PD-L1+ populations with mTNBC
Peter Schmid
1:01
Highlights in breast and gynecological cancer at ESTRO 2022
Pedro Lara
1:22
Drug shortages around the world: why communication is key
Fatima Cardoso
2:13
HER-2 conversion: a phenomenon in trastuzumab resistance
Russell Petty
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals